Results 31 to 40 of about 18,010 (199)

Complete genome sequences of KPC-producing <i>Klebsiella pneumoniae</i> isolates pre- and post-development of meropenem/vaborbactam resistance. [PDF]

Microbiol Resour Announc
Ozer EA, Nozick SH, Singh N, Watkins JV, Hauser AR, Bulman ZP.   +5 more
europepmc   +2 more sources

Targeting carbapenem-resistant and hypervirulent Klebsiella pneumoniae: in vitro evaluation of cefepime/zidebactam, aztreonam/avibactam, imipenem/relebactam, and meropenem/vaborbactam. [PDF]

BMC Infect Dis
Li Y, Li Y, Jia X, Mao H, Li D, Zhang J.
europepmc   +2 more sources

Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis. [PDF]

Antimicrob Agents Chemother
Mohammad S, Al Namer Y, Rahimeh W, Albalas M, Almangour TA.   +4 more
europepmc   +2 more sources

P-1210. Real-World Efficacy and Safety of Meropenem-Vaborbactam in Patients with Moderate to Severe Renal Impairment [PDF]

Open Forum Infect Dis
Sean R Van Helden, Kaylee E Caniff, Mohammed I. Al Musawa, Sara Alosaimy, Abdalhamid M Lagnf, Chloe Judd, Marco R. Scipione, Jing Zhao, Taryn A Eubank, Kevin W. Garey, Wesley D Kufel, Tamara Krekel, Karen K. Tan, Elisabeth Chandler, Jacqueline A Aramburo, Dev Chatterji, Samantha D. Walker, Christine Yost, Jacqueline M Muscat, Justin Andrade, John Cerenzio, Karan Raja, Taylor Morrisette, Sarah C J Jorgensen, Ryan P. Mynatt, Travis J Carlson, David W. Allen, Kailynn DeRonde, Ana Vega, Lilian Abbo, Veena Venugopalan, Vasilios Athans, Steve Saw, Kimberly C Claeys, Matthew Miller, Kyle C. Molina, Lee Amaya, Jessica K. Ortwine, Michael P Veve, Michael J Rybak   +39 more
europepmc   +2 more sources

P-1325. A Comparative Analysis of Ceftazidime-avibactam and Meropenem-vaborbactam in the Treatment of Carbapenem-resistant Enterobacterales Infections [PDF]

Open Forum Infect Dis
Kyle Crooker, Alana Pinheiro Alves, Denise Nunes Araújo, Johnny Zakhour, Madison Patrus, Anita Shallal, Geehan Suleyman, Ulyana Malovana   +7 more
europepmc   +2 more sources

Meropenem/vaborbactam activity against carbapenem-resistant Klebsiella pneumoniae from catheter-related bloodstream infections. [PDF]

Front Cell Infect Microbiol
Sivori F, Francalancia M, Truglio M, Cavallo I, Pronesti C, Fabrizio G, Celesti I, Cazzani A, Furzi L, Pimpinelli F, Di Domenico EG.   +10 more
europepmc   +3 more sources

Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates

Microbiology Spectrum, 2023
Carbapenems are a common first-line therapy for serious Gram-negative infections, but carbapenem-resistant Enterobacterales (CRE) isolates have become an urgent health concern. Klebsiella pneumoniae serine carbapenemases (KPCs) now have been disseminated
Dee Shortridge, Valerie Kantro, Mariana Castanheira   +2 more
doaj   +1 more source

P-1319. Antimicrobial Activity of Aztreonam-Avibactam and Molecular Characterization of Enterobacterales Resistant to Ceftazidime-Avibactam and/or Meropenem-Vaborbactam from United States Medical Centers (2016-2024) [PDF]

Open Forum Infect Dis
Helio SaderJohn Kimbrough, Zachary Kockler, Dmitri Debabov, Rodrigo E. Mendes, Mariana Castanheira   +4 more
europepmc   +2 more sources

Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation

mSphere, 2023
To evaluate the resistance mechanisms among Pseudomonas aeruginosa clinical isolates exhibiting meropenem (MEM) MIC values higher than meropenem-vaborbactam (MEV). P.
Mariana Castanheira, Timothy B. Doyle, Cory M. Hubler, Sean DeVries, Dee Shortridge   +4 more
doaj   +1 more source

Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study. [PDF]

Open Forum Infect Dis
Background Meropenem-vaborbactam is a recent and promising option for the treatment of KPC-producing Klebsiella pneumoniae (KPC-Kp) infections, including those resistant to ceftazidime-avibactam.Methods We conducted a retrospective analysis of ...
Tumbarello M, Raffaelli F, Giannella M, De Pascale G, Cascio A, De Rosa FG, Cattelan AM, Oliva A, Saracino A, Bassetti M, Mussini C, Luzzati R, Capone A, Signorini L, Bartoletti M, Sambo M, Sarmati L, Antinori S, Mularoni A, Tascini C, Corona A, Pascale R, Rubino R, Corcione S, Mazzitelli M, Giuliano G, Lovecchio A, Bavaro DF, Meschiari M, Montagnani F, Fabbiani M, De Benedetto I, Antonelli M, Venditti M, Viale P.   +34 more
europepmc   +7 more sources